187 related articles for article (PubMed ID: 26946532)
1. Original Research: Generation of non-deletional hereditary persistence of fetal hemoglobin β-globin locus yeast artificial chromosome transgenic mouse models: -175 Black HPFH and -195 Brazilian HPFH.
Braghini CA; Costa FC; Fedosyuk H; Neades RY; Novikova LV; Parker MP; Winefield RD; Peterson KR
Exp Biol Med (Maywood); 2016 Apr; 241(7):697-705. PubMed ID: 26946532
[TBL] [Abstract][Full Text] [Related]
2. {gamma}-Globin gene expression in chemical inducer of dimerization (CID)-dependent multipotential cells established from human {beta}-globin locus yeast artificial chromosome ({beta}-YAC) transgenic mice.
Blau CA; Barbas CF; Bomhoff AL; Neades R; Yan J; Navas PA; Peterson KR
J Biol Chem; 2005 Nov; 280(44):36642-7. PubMed ID: 16131492
[TBL] [Abstract][Full Text] [Related]
3. Mi2β is required for γ-globin gene silencing: temporal assembly of a GATA-1-FOG-1-Mi2 repressor complex in β-YAC transgenic mice.
Costa FC; Fedosyuk H; Chazelle AM; Neades RY; Peterson KR
PLoS Genet; 2012; 8(12):e1003155. PubMed ID: 23284307
[TBL] [Abstract][Full Text] [Related]
4. Use of yeast artificial chromosomes (YACs) in studies of mammalian development: production of beta-globin locus YAC mice carrying human globin developmental mutants.
Peterson KR; Li QL; Clegg CH; Furukawa T; Navas PA; Norton EJ; Kimbrough TG; Stamatoyannopoulos G
Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5655-9. PubMed ID: 7539923
[TBL] [Abstract][Full Text] [Related]
5. High levels of human gamma-globin gene expression in adult mice carrying a transgene of deletion-type hereditary persistence of fetal hemoglobin.
Arcasoy MO; Romana M; Fabry ME; Skarpidi E; Nagel RL; Forget BG
Mol Cell Biol; 1997 Apr; 17(4):2076-89. PubMed ID: 9121456
[TBL] [Abstract][Full Text] [Related]
6. High levels of human gamma-globin are expressed in adult mice carrying a transgene of the Brazilian type of hereditary persistence of fetal hemoglobin ((A)gamma -195).
da Cunha AF; Brugnerotto AF; Corat MA; Devlin EE; Gimenes AP; de Melo MB; Passos LA; Bodine D; Saad ST; Costa FF
Hemoglobin; 2009; 33(6):439-47. PubMed ID: 19958189
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobin.
Ravi NS; Wienert B; Wyman SK; Bell HW; George A; Mahalingam G; Vu JT; Prasad K; Bandlamudi BP; Devaraju N; Rajendiran V; Syedbasha N; Pai AA; Nakamura Y; Kurita R; Narayanasamy M; Balasubramanian P; Thangavel S; Marepally S; Velayudhan SR; Srivastava A; DeWitt MA; Crossley M; Corn JE; Mohankumar KM
Elife; 2022 Feb; 11():. PubMed ID: 35147495
[TBL] [Abstract][Full Text] [Related]
8. Juxtaposition of the HPFH2 enhancer is not sufficient to reactivate the gamma-globin gene in adult erythropoiesis.
Xiang P; Han H; Barkess G; Olave I; Fang X; Yin W; Stamatoyannopoulos G; Li Q
Hum Mol Genet; 2005 Oct; 14(20):3047-56. PubMed ID: 16155112
[TBL] [Abstract][Full Text] [Related]
9. A natural regulatory mutation in the proximal promoter elevates fetal
Martyn GE; Wienert B; Kurita R; Nakamura Y; Quinlan KGR; Crossley M
Blood; 2019 Feb; 133(8):852-856. PubMed ID: 30617196
[TBL] [Abstract][Full Text] [Related]
10. Featured Article: Modulation of fetal hemoglobin in hereditary persistence of fetal hemoglobin deletion type-2, compared to Sicilian δβ-thalassemia, by BCL11A and SOX6-targeting microRNAs.
Fornari TA; Lanaro C; Albuquerque DM; Ferreira R; Costa FF
Exp Biol Med (Maywood); 2017 Feb; 242(3):267-274. PubMed ID: 27591578
[TBL] [Abstract][Full Text] [Related]
11. Developmental regulation of human gamma- and beta-globin genes in the absence of the locus control region.
Starck J; Sarkar R; Romana M; Bhargava A; Scarpa AL; Tanaka M; Chamberlain JW; Weissman SM; Forget BG
Blood; 1994 Sep; 84(5):1656-65. PubMed ID: 7520781
[TBL] [Abstract][Full Text] [Related]
12. Deletion of a region that is a candidate for the difference between the deletion forms of hereditary persistence of fetal hemoglobin and deltabeta-thalassemia affects beta- but not gamma-globin gene expression.
Calzolari R; McMorrow T; Yannoutsos N; Langeveld A; Grosveld F
EMBO J; 1999 Feb; 18(4):949-58. PubMed ID: 10022837
[TBL] [Abstract][Full Text] [Related]
13. Sequences located 3' to the breakpoint of the hereditary persistence of fetal hemoglobin-3 deletion exhibit enhancer activity and can modify the developmental expression of the human fetal A gamma-globin gene in transgenic mice.
Anagnou NP; Perez-Stable C; Gelinas R; Costantini F; Liapaki K; Constantopoulou M; Kosteas T; Moschonas NK; Stamatoyannopoulos G
J Biol Chem; 1995 Apr; 270(17):10256-63. PubMed ID: 7537267
[TBL] [Abstract][Full Text] [Related]
14. G gamma A gamma (beta+) hereditary persistence of fetal hemoglobin: the G gamma -158 C-->T mutation in cis to the -175 T-->C mutation of the A gamma-globin gene results in increased G gamma-globin synthesis.
Coleman MB; Adams JG; Steinberg MH; Plonczynski MW; Harrell AH; Castro O; Winter WP
Am J Hematol; 1993 Feb; 42(2):186-90. PubMed ID: 7679879
[TBL] [Abstract][Full Text] [Related]
15. T to C substitution at -175 or -173 of the gamma-globin promoter affects GATA-1 and Oct-1 binding in vitro differently but can independently reproduce the hereditary persistence of fetal hemoglobin phenotype in transgenic mice.
Liu LR; Du ZW; Zhao HL; Liu XL; Huang XD; Shen J; Ju LM; Fang FD; Zhang JW
J Biol Chem; 2005 Mar; 280(9):7452-9. PubMed ID: 15613485
[TBL] [Abstract][Full Text] [Related]
16. Activation of the beta-like globin genes in transgenic mice is dependent on the presence of the beta-locus control region.
Navas PA; Li Q; Peterson KR; Swank RA; Rohde A; Roy J; Stamatoyannopoulos G
Hum Mol Genet; 2002 Apr; 11(8):893-903. PubMed ID: 11971871
[TBL] [Abstract][Full Text] [Related]
17. A genome-editing strategy to treat β-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition.
Traxler EA; Yao Y; Wang YD; Woodard KJ; Kurita R; Nakamura Y; Hughes JR; Hardison RC; Blobel GA; Li C; Weiss MJ
Nat Med; 2016 Sep; 22(9):987-90. PubMed ID: 27525524
[TBL] [Abstract][Full Text] [Related]
18. Disrupting the adult globin promoter alleviates promoter competition and reactivates fetal globin gene expression.
Topfer SK; Feng R; Huang P; Ly LC; Martyn GE; Blobel GA; Weiss MJ; Quinlan KGR; Crossley M
Blood; 2022 Apr; 139(14):2107-2118. PubMed ID: 35090172
[TBL] [Abstract][Full Text] [Related]
19. A fetal globin gene mutation in A gamma nondeletion hereditary persistence of fetal hemoglobin increases promoter strength in a nonerythroid cell.
Rixon MW; Gelinas RE
Mol Cell Biol; 1988 Feb; 8(2):713-21. PubMed ID: 2451123
[TBL] [Abstract][Full Text] [Related]
20. A single point mutation is the cause of the Greek form of hereditary persistence of fetal haemoglobin.
Berry M; Grosveld F; Dillon N
Nature; 1992 Aug; 358(6386):499-502. PubMed ID: 1379347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
